Human KIR3DL3 Protein (KR3-HM4L3)

  • Express System: Expi293
  • Product Tag: C-His-Avi
  • Purity: > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC
  • Activity: The affinity constant of 334 nM as determined in SPR assay (Biacore T200). See testing image for detail.
  • Exact Sequence: Glu26-Leu322

Catalog: KR3-HM4L3

$375.00
Size:

Order now get it on

Product Description Recombinant Human KIR3DL3 Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal.It contains Glu26-Leu322.
Product Category Recombinant Protein
Target KIR3DL3
Synonyms CD158Z; KIR2DS2; KIR3DL7; KIR44; KIRC1; KIR3DL3
Gene/Protein ID Q8N743
Species Human
Exact Sequence Glu26-Leu322
Molecular Weight The protein has a predicted MW of 35.3 kDa. Due to glycosylation, the protein migrates to 48-52 kDa based on Tris-Bis PAGE result.
Activity The affinity constant of 334 nM as determined in SPR assay (Biacore T200). See testing image for detail.
Product Tag C-His-Avi
Express System Expi293
Purity > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC
Endotoxin Less than 1EU per μg by the LAL method.
Form Lyophilized
Shipping Shipped at ambient temperature.
Formulation Lyophilized from 0.22μm filtered solution in 20mM Tris, 150mM NaCl, 0.2M L-Arginine (pH 8.2). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Stability And Storage Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Human B7-H7, hFc Tag captured on CM5 Chip via Protein A can bind Human KIR3DL3, His Tag with an affinity constant of 334 nM as determined in SPR assay (Biacore T200).
The purity of Human KIR3DL3 is greater than 95% as determined by SEC-HPLC.
Human KIR3DL3 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

You may also be interested in